All US holdings of this investor are reported in this report. Top holdings included HES, PXD, UNH, IQV, and EXEL. Confidential Treatment Requested (one or more holding(s) omitted).
Showing stock holdings,
see here
for options holdings
FARALLON CAPITAL MANAGEMENT LLC Q1 2024 Portfolio
Sym
Weight
Trade Impact
Company
Class
Share Change
Activity
Value Change $
Value $
* Price $
Shares
Principal
Filing 2024 Q1 - Restatement compared to 2023 Q4 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
Confidential Treatment Requested. (The Manager has omitted from this public Form 13F one or more holding(s) for which it is requesting confidential treatment from the U.S. Securities and Exchange Commission pursuant to section 13(f) of the Exchange Act and rule 24b-2 thereunder)
Person Signing this Report on Behalf of Reporting Manager:
Name
Title
City, State
Date
John R. Warren
Managing Member
San Francisco, California
24 May 2024
This Amendment is a restatement of the Form 13F-HR filed on May 15, 2024 with respect to the quarter ended March 31, 2024. It corrects holdings information with respect to one position that was reported in such Form 13F-HR.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.